PFKFB4 Overexpression Facilitates Proliferation by Promoting the G1/S Transition and is Associated with a Poor Prognosis in Triple-Negative Breast Cancer

Abstract Background:6-Phosphofructo-2-kinase/fructose-2,6-biphosphate-4 (PFKFB4) is a key factor that plays an important role in tumorigenesis. However, its role in triple-negative breast cancer (TNBC) progression needs to be further validated.We investigated whether PFKFB4 is directly involved in the oncogenic signaling networks of TNBC. Methods: First, we assessed the expression level of PFKFB4 in tumor tissue specimens by immunohistochemistry and evaluated its prognostic value. Next, the effect of PFKFB4 on TNBC cell growth and associated mechanisms were investigated.Finally, the results were further verified in vivo. Results: We found that PFKFB4 overexpression was associated with an unfavorable prognosis in TNBC patients. PFKFB4 was overexpressed in TNBC cell lines in hypoxic environments, and its overexpression promoted tumor progression in vitro and in vivo. Further analyses demonstrated that the possible mechanism might be that PFKFB4 overexpression facilitates TNBC progression by enhancing the G1/S phase transition by increasing the proteinlevelof CDK6 and phosphorylation of Rb. Conclusions: These data suggest that PFKFB4 plays significant roles in the tumorigenesis and development of TNBC.Trial registration: Retrospectively registered.